15 
included on the protection of proprietary information and 
patent rights. As you know, it is a recent NIH decision that 
recombinant DNA research inventions developed under DHEW sup- 
port may be patented by institutions, subject to the condition 
that licensees will abide by the safety standards of the NIH 
Guidelines. Would the Committee object to a provision on 
disclosure of information that would set general policy guide- 
lines in regard to patents? 
[516] 
